Literature DB >> 15730924

Effect of hepatitis C virus core protein on modulation of cellular proliferation and apoptosis in hilar cholangiocarcinoma.

Ru-Fu Chen1, Zhi-Hua Li, Sheng-Quan Zou, Ji-Sheng Chen.   

Abstract

BACKGROUND: Hepatitis C virus (HCV) is believed to be an important human pathogen causing carcinoma. But the effect of HCV infection on the alteration of cellular proliferation and apoptosis and the relationship between the effect and the development of hilar cholangiocarcinoma are largely unknown. The aim of this study was to assess the effect of HCV core protein on proliferation and apoptosis of hilar cholangiocarcinoma.
METHODS: HCV core protein (HCV C protein) was detected by peroxidase-antiperoxidase assay in surgical specimens from 48 patients with hilar cholangiocarcinoma. The apoptosis index (AI) and PCNA index (PI) in hilar cholangiocarcinoma were detected by in situ end labeling assay and streptavidin-biotin assay respectively.
RESULTS: The expression of HCV C protein was observed in 32 (67.7%) of the 48 specimens of hilar cholangiocarcinoma. The mean+/-standard deviation for AI and PI was 3.52%+/-0.64% and 46.24%+/-11.46% respectively. The AI of hilar cholangiocarcinoma specimens with HCV C protein expression was significantly lower than that of HCV C protein negative specimens (P<0.01), whereas the PI of HCV C protein positive specimens was significantly higher than that of HCV C protein negative specimens (P<0.01).
CONCLUSION: HCV C protein may promote the cellular proliferation of hilar cholangiocarcinoma and inhibit its cellular apoptosis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15730924

Source DB:  PubMed          Journal:  Hepatobiliary Pancreat Dis Int


  9 in total

1.  Biological impact of hepatitis B virus X-hepatitis C virus core fusion gene on human hepatocytes.

Authors:  Zhen Ma; Qin-Hai Shen; Guo-Min Chen; Da-Zhi Zhang
Journal:  World J Gastroenterol       Date:  2008-09-21       Impact factor: 5.742

Review 2.  Cholangiocarcinoma: modern advances in understanding a deadly old disease.

Authors:  Harmeet Malhi; Gregory J Gores
Journal:  J Hepatol       Date:  2006-09-25       Impact factor: 25.083

3.  Hepatitis C virus infection and the risk of cancer among elderly US adults: A registry-based case-control study.

Authors:  Parag Mahale; Harrys A Torres; Jennifer R Kramer; Lu-Yu Hwang; Ruosha Li; Eric L Brown; Eric A Engels
Journal:  Cancer       Date:  2017-01-24       Impact factor: 6.860

4.  Risk factors for hilar cholangiocarcinoma: a case-control study in China.

Authors:  Wen-Ke Cai; Hui Sima; Ben-Dong Chen; Guang-Shun Yang
Journal:  World J Gastroenterol       Date:  2011-01-14       Impact factor: 5.742

5.  Risk of hepatobiliary and pancreatic cancers after hepatitis C virus infection: A population-based study of U.S. veterans.

Authors:  Hashem B El-Serag; Eric A Engels; Ola Landgren; Elizabeth Chiao; Louise Henderson; Harshinie C Amaratunge; Thomas P Giordano
Journal:  Hepatology       Date:  2009-01       Impact factor: 17.425

6.  Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based case-control study.

Authors:  Tania M Welzel; Barry I Graubard; Hashem B El-Serag; Yasser H Shaib; Ann W Hsing; Jessica A Davila; Katherine A McGlynn
Journal:  Clin Gastroenterol Hepatol       Date:  2007-08-06       Impact factor: 11.382

Review 7.  Hepatitis C virus infection and the risk of intrahepatic cholangiocarcinoma and extrahepatic cholangiocarcinoma: evidence from a systematic review and meta-analysis of 16 case-control studies.

Authors:  Hao Li; Bin Hu; Zun-Qiang Zhou; Jiao Guan; Zheng-Yun Zhang; Guang-Wen Zhou
Journal:  World J Surg Oncol       Date:  2015-04-23       Impact factor: 2.754

8.  Prognostic impact of hepatitis B or C on intrahepatic cholangiocarcinoma.

Authors:  Jung Woong Seo; Byung Soo Kwan; Young Koog Cheon; Tae Yoon Lee; Chan Sup Shim; So Young Kwon; Won Hyeok Choe; Byung Chul Yoo; Jeong Min Yoon; Jung Hoon Lee
Journal:  Korean J Intern Med       Date:  2020-01-10       Impact factor: 2.884

9.  Treatment outcomes and prognostic factors of intrahepatic cholangiocarcinoma.

Authors:  Renumathy Dhanasekaran; Alan W Hemming; Ivan Zendejas; Thomas George; David R Nelson; Consuelo Soldevila-Pico; Roberto J Firpi; Giuseppe Morelli; Virginia Clark; Roniel Cabrera
Journal:  Oncol Rep       Date:  2013-02-18       Impact factor: 3.906

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.